title: Applications of viral nanoparticles in medicine.
abstract: Several nanoparticle platforms are currently being developed for applications in medicine, including both synthetic materials and naturally occurring bionanomaterials such as viral nanoparticles (VNPs) and their genome-free counterparts, virus-like particles (VLPs). A broad range of genetic and chemical engineering methods have been established that allow VNP/VLP formulations to carry large payloads of imaging reagents or drugs. Furthermore, targeted VNPs and VLPs can be generated by including peptide ligands on the particle surface. In this article, we highlight state-of-the-art virus engineering principles and discuss recent advances that bring potential biomedical applications a step closer. Viral nanotechnology has now come of age and it will not be long before these formulations assume a prominent role in the clinic.
authors: Department of Biomedical Engineering, Case Western Reserve University, Cleveland, OH 44106, USA.
authors: Ibrahim
authors: I
authors: Yildiz
authors: Sourabh
authors: S
authors: Shukla
authors: Nicole F
authors: NF
authors: Steinmetz
references: J Control Release. 2007 Jul 16;120(1-2):41-50
references: 17512998
references: Mol Imaging Biol. 2008 Jul-Aug;10(4):182-91
references: 18437498
references: J Am Chem Soc. 2009 Dec 2;131(47):17093-5
references: 19904938
references: Nano Lett. 2010 Mar 10;10(3):1093-7
references: 20163184
references: ACS Nano. 2009 Mar 24;3(3):691-9
references: 19226129
references: Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2010 May-Jun;2(3):249-59
references: 20166124
references: ACS Nano. 2010 Feb 23;4(2):589-94
references: 20175564
references: Nat Biotechnol. 2006 Oct;24(10):1211-7
references: 17033654
references: Langmuir. 2007 Nov 20;23(24):12280-6
references: 17949022
references: Magn Reson Med. 2005 Oct;54(4):807-12
references: 16155869
references: Cancer Immunol Immunother. 2010 Nov;59(11):1685-96
references: 20652244
references: Mol Pharm. 2011 Feb 7;8(1):29-43
references: 21047140
references: Expert Rev Mol Diagn. 2009 May;9(4):325-41
references: 19435455
references: Nat Methods. 2008 Sep;5(9):763-75
references: 18756197
references: Proc Natl Acad Sci U S A. 2002 Feb 5;99(3):1527-31
references: 11830668
references: Chem Biol. 2002 Jul;9(7):813-9
references: 12144925
references: Biophys J. 2008 Feb 15;94(4):1428-36
references: 17981893
references: Structure. 2007 Apr;15(4):461-72
references: 17437718
references: Curr Gene Ther. 2003 Dec;3(6):545-65
references: 14683451
references: J Gene Med. 2004 Jun;6(6):597-602
references: 15170730
references: J Am Chem Soc. 2010 May 5;132(17):5936-7
references: 20392049
references: Mol Cancer Ther. 2009 Aug;8(8):2383-91
references: 19671758
references: J Virol. 2008 Oct;82(19):9546-54
references: 18667514
references: J Gen Virol. 2006 Sep;87(Pt 9):2749-2754
references: 16894216
references: J Am Chem Soc. 2007 Mar 21;129(11):3104-9
references: 17319656
references: Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2011 Mar-Apr;3(2):174-196
references: 20872839
references: Antimicrob Agents Chemother. 2006 Jun;50(6):2087-97
references: 16723570
references: ACS Nano. 2008 May;2(5):1040-50
references: 19206502
references: Nature. 1984 Jan 12-18;307(5947):178-80
references: 6318124
references: Nanomedicine (Lond). 2011 Feb;6(2):351-64
references: 21385137
references: J Mol Biol. 2007 Aug 17;371(3):812-35
references: 17585939
references: Adv Protein Chem. 2003;64:1-36
references: 13677044
references: Chem Commun (Camb). 2008 Jan 7;(1):88-90
references: 18401897
references: Annu Rev Anal Chem (Palo Alto Calif). 2008;1:801-32
references: 20636098
references: Chem Commun (Camb). 2009 Jun 28;(24):3497-510
references: 19521593
references: Org Biomol Chem. 2007 Jan 7;5(1):54-7
references: 17164905
references: Nat Protoc. 2010 Aug;5(8):1406-17
references: 20671724
references: ACS Nano. 2011 Feb 22;5(2):1243-52
references: 21210643
references: Nano Lett. 2006 Sep;6(9):1993-9
references: 16968014
references: Nat Rev Genet. 2007 Aug;8(8):573-87
references: 17607305
references: PLoS Pathog. 2009 May;5(5):e1000417
references: 19412526
references: Immunology. 2008 Jun;124(2):186-97
references: 18070030
references: Cell. 2006 Apr 21;125(2):385-98
references: 16630824
references: ACS Nano. 2010 Jul 27;4(7):3853-60
references: 20575505
references: Bioconjug Chem. 2007 May-Jun;18(3):836-43
references: 17407258
references: Nat Med. 2006 Mar;12(3):354-60
references: 16501571
references: J Immunol. 2004 Oct 1;173(7):4308-16
references: 15383559
references: ACS Nano. 2010 Oct 26;4(10):6014-20
references: 20863095
references: Int J Nanomedicine. 2007;2(4):715-33
references: 18203438
references: Cytotechnology. 1994;15(1-3):145-55
references: 7765926
references: Chem Commun (Camb). 2007 Mar 28;(12):1269-71
references: 17356779
references: Intervirology. 2002;45(4-6):371-80
references: 12602361
references: Small. 2011 Jun 20;7(12):1664-72
references: 21520408
references: J Am Chem Soc. 2008 Feb 27;130(8):2546-52
references: 18247608
references: Nanomedicine (Lond). 2011 Jan;6(1):55-68
references: 21182418
references: J Virol Methods. 2004 Jan;115(1):99-104
references: 14656466
references: Small. 2009 Mar;5(6):718-26
references: 19242943
references: IEEE Trans Nanobioscience. 2008 Sep;7(3):223-32
references: 18779103
references: Biomed Pharmacother. 2009 May;63(4):313-8
references: 18823738
references: Biomacromolecules. 2009 Apr 13;10(4):784-92
references: 19281149
references: AIDS. 1993 Oct;7(10):1315-23
references: 8267904
references: Cancer Cell. 2009 Dec 8;16(6):510-20
references: 19962669
references: J Struct Biol. 2003 Dec;144(3):253-61
references: 14643194
references: J Cell Biol. 2010 Mar 22;188(6):759-68
references: 20231381
references: Nat Nanotechnol. 2009 Apr;4(4):259-64
references: 19350038
references: Adv Drug Deliv Rev. 2008 May 22;60(8):915-28
references: 18325628
references: Angew Chem Int Ed Engl. 2010 Apr 26;49(19):3280-94
references: 20401880
references: Nano Lett. 2006 Jun;6(6):1160-4
references: 16771573
references: Lancet Oncol. 2005 May;6(5):271-8
references: 15863374
references: Trends Mol Med. 2009 Jan;15(1):32-9
references: 19101205
references: Biochem Soc Trans. 2004 Jun;32(Pt3):397-402
references: 15157146
references: J Virol Methods. 2010 Jun;166(1-2):77-85
references: 20219539
references: J Virol. 2006 Nov;80(21):10395-406
references: 16920821
references: Biomacromolecules. 2003 May-Jun;4(3):472-6
references: 12741758
references: J Am Chem Soc. 2007 Mar 7;129(9):2628-35
references: 17266310